Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA set to evaluate use of ‘ecstasy’ for treating PTSD
The party drug could soon be prescribed, in conjunction with psychological interventions, as a treatment for mental health disorders.
Ascension reverts to pen-and-paper operations after ransomware attack
Most of Ascension's retail pharmacies nationwide are unable to fill prescriptions or accept payments. During the outage, patients are being given pen-on-paper scripts.
FDA announces another new recall involving Abbott’s HeartMate 3 LVADs after 70 injuries, 2 deaths
Abbott issued the new recall after receiving more than 80 reports of blood or air entering the LVAD during implant procedures. Customers can still use these devices, but they are advised to follow specific steps to limit the risk of complications.
Cardiology ranked No. 2 among all specialties with 122 FDA-cleared AI models
Only radiology is associated with more FDA-cleared AI algorithms than cardiology, according to new federal data.
PaceMate names former Philips, BioTelemetry leader its new chief commercial officer
JR Finkelmeier has more than 20 years of experience in the healthcare and medical device industries.

AHA President Michelle Albert explains what can be done to boost healthcare equity and diversity in cardiology.

AHA President Michelle Albert on addressing health equity issues in cardiology

American Heart Association President Michelle Albert, MD, talked to us about about how to address health inequities in cardiology departments.

February 16, 2023

Manufacturers, health organizations unite to address medical supply chain

The newly formed group, the American Medical Manufacturers Association, includes Altor Safety, Aquaspersions USA, Blue Star NBR, Lutema, Ochsner Health, Premium-PPE, SafeSource Direct, United Safety Technology and Vizient as its initial members.

February 15, 2023

Private equity investors have grown more and more interested in cardiology in recent years. Roger Strode, a partner with the global law firm Foley and Lardner LLP, explains why this is.

Q&A: What the rise of private equity investments in cardiology means for cardiologists and their patients

Private equity investors have grown more and more interested in cardiology in recent years. Why the sudden shift? And what does it mean for patient care going forward?

February 15, 2023

No new COVID-19 variants emerged in latest outbreak in China

More than 90% of local infections in Beijing between Nov. 14 and Dec. 20, 2022, were BA.5.2 and BF.7, two existing Omicron sub-variants of COVID-19.

February 13, 2023

HHS issues guidance as COVID-19 PHE winds down

The guidance clarifies what will and will not be impacted by the sunset of the PHE on May 11.

February 10, 2023

A busy week for cardiology investments: 3 tech companies report big financing rounds

It’s not even Valentine’s Day yet, but February has already been a big month for fundraising in the cardiology space.

February 9, 2023

Healthcare workforce management company raises $200M

The funding comes at a time when the healthcare workforce is facing a major labor crunch.

February 8, 2023

Hundreds of doctors on the front lines died taking care of COVID-19 patients

Between March 2020 and December 2021, 622 physicians deaths were attributed to the COVID-19 pandemic.

February 7, 2023

Around the web

AI in Healthcare

About that bipartisan $32B ‘roadmap’ for AI policy: What’s in it for healthcare?

This week Washington took a major step toward nailing down a solid game plan on federal AI spending for everything outside of defense.

Cardiovascular Business

FDA announces new recall of delivery catheters after patient’s death

The recall includes specific lots of five different medical devices used to treat stroke and other neurovascular diseases.

Cardiovascular Business

FDA warns against use of troubled heart devices, citing ‘continued concerns’ after multiple recalls

The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible.

Clinical

FDA set to evaluate use of ‘ecstasy’ for treating PTSD

Ascension reverts to pen-and-paper operations after ransomware attack

FDA announces another new recall involving Abbott’s HeartMate 3 LVADs after 70 injuries, 2 deaths

Cardiology ranked No. 2 among all specialties with 122 FDA-cleared AI models

PaceMate names former Philips, BioTelemetry leader its new chief commercial officer

Around the web